Northwire Canada EditionSaturday, July 11, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Financings

ReGen III Closes Second Tranche of Private Placement

GIII · Price

Executive Summary

  • ReGen III Corp. closed the second tranche of its non‑brokered private placement, issuing 7,650,000 Units at $0.20 each for gross proceeds of $1,530,000.
  • Combined with the initial tranche, total units issued to date equal 17,187,860 for aggregate gross proceeds of $3,437,572; a third and final tranche is expected to close on or before April 1, 2026 targeting a total of $4 M.
  • Proceeds are earmarked for working capital, general corporate purposes, and repayment of debt; insiders subscribed for 2,875,000 Units, constituting a related‑party transaction exempt from MI 61‑101 valuation/approval thresholds.

Key Details

  • Units Issued – Second Tranche: 7,650,000 Units @ $0.20 per Unit → Gross proceeds: $1,530,000.
  • Unit Composition: 1 common share + ½ of a common share purchase warrant; each warrant allows purchase of one additional share at $0.30 for three years from issuance.
  • Hold Period: Statutory four‑month hold ending July 28, 2026.
  • Finder’s Fees Paid: $47,750 (cash).
  • Total Issuance to Date: 17,187,860 Units → Aggregate gross proceeds: $3,437,572.
  • Planned Final Tranche: Target total gross proceeds of $4 M; expected closing ≤ April 1, 2026.
  • Use of Proceeds: Working capital, general corporate purposes, repayment of debt.
  • Related‑Party Participation: Insiders subscribed for 2,875,000 Units; transaction qualifies for MI 61‑101 exemption (valuation < 25% of market cap).
  • Regulatory Conditions: Closing subject to required approvals, including final TSX Venture Exchange approval.
  • U.S. Securities Restrictions: Securities not registered under the U.S. 1933 Act; cannot be offered/sold in the United States or to U.S. persons except via exemption.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from ReGen III Corp.